Pharmaceutical Technology47m
FDA expands Pfizer’s RSV vaccine label to include all high-risk adults
Abrysvo is now approved to prevent lower respiratory tract disease caused by RSV in high-risk adults over 18 years of age.
Pharmaceutical Technology2h
Ocuphire and Opus Genetics merge to develop IRD gene therapy
Ocuphire Pharma has announced the acquisition of Opus Genetics to develop gene therapies for inherited retinal diseases (IRDs ...
Pharmaceutical Technology5h
FDA approves Alvotech and Teva’s SELARSDI for new indications
The FDA has approved a new presentation of Alvotech and Teva’s SELARSDI, for the treatment of ulcerative colitis and Crohn's ...
Pharmaceutical Technology6h
AAO 2024: NMA reveals Vabysmo’s superior CST improvement over Eylea HD
This NMA serves to bridge the gap between trials for both therapies and compare them to one another based on existing data.
Pharmaceutical Technology8h
Health Canada approves Servier’s VORANIGO for IDH-mutant glioma
Servier Canada has announced Health Canada's approval of VORANIGO for Grade 2 IDH-mutant glioma in adults and paediatric ...
Pharmaceutical Technology9h
A slow start for self-amplifying mRNA vaccines
A year after the first samRNA vaccine approval, experts say others are likely to face scientific and regulatory hurdles.
Pharmaceutical Technology1d
Gilead and MSD to advance once-weekly HIV treatment to Phase III
The companies have presented positive Phase II data during an oral session at IDWeek 2024, in Los Angeles, US.
Pharmaceutical Technology1d
Editas and Genevant team up to develop gene editing therapies
Editas is partnering its CRISPR platform with Genevant’s LNP technology to develop novel gene editing medicines in a deal ...
Pharmaceutical Technology1d
World Osteoporosis Day calls for urgent action to prevent fragility fractures
The IOF highlights the importance of collaborative efforts in treating osteoporosis, ensuring appropriate care globally.